Diabetic foot ulcers (DFUs) are a common complication of diabetes, and with the increasing prevalence of diabetes across all markets, the number of patients suffering from DFUs is also expected to rise. Despite the availability of various treatment modalities, there […]
January 2014 Life Science Industry Research Reports
Twinrix (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Pediarix (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Hexyon (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Heplisav (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Fendrix (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Engerix-B (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
Comvax (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]